CHC – The Cancer & Hematology Centers

Helsinn (ANAM)

A Phase III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in adult patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Principal Investigator: Dr. Yuanbin Chen

For more information on this trial, read its profile on here.